BIO-key resumes Nasdaq trading after regaining compliance.

BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing requirements. This regulatory clearance mitigates the risk of direct delisting and restores access to capital markets for the biometric authentication provider.